CRISPR Therapeutics
CRSP
CRSP
429 hedge funds and large institutions have $3.52B invested in CRISPR Therapeutics in 2025 Q2 according to their latest regulatory filings, with 101 funds opening new positions, 125 increasing their positions, 100 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% more funds holding
Funds holding: 391 → 429 (+38)
8.96% more ownership
Funds ownership: 74.83% → 83.78% (+9%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Holders
429
Holding in Top 10
6
Calls
$244M
Puts
$186M
Top Buyers
| 1 | +$168M | |
| 2 | +$58.4M | |
| 3 | +$49.9M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$41.8M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$37.5M |
Top Sellers
| 1 | -$48.1M | |
| 2 | -$38.4M | |
| 3 | -$25M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$23.3M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$22.3M |
